Thanks for the update on EIR report. Well worth keeping a eye on this one and doing your own research.Emma, how's it going with your other stocks. Always look forward to your views.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%